Kanner Steven 4
4 · Caribou Biosciences, Inc. · Filed May 17, 2022
Insider Transaction Report
Form 4
Kanner Steven
Chief Scientific Officer
Transactions
- Exercise/Conversion
Option to purchase Common Stock
2022-05-13−68,306→ 3,534 totalExercise: $1.81Exp: 2027-07-11→ Common Stock (68,306 underlying) - Exercise/Conversion
Common Stock
2022-05-13$2.69/sh+6,114$16,447→ 302,059 total - Exercise/Conversion
Common Stock
2022-05-13$1.81/sh+68,306$123,634→ 295,945 total - Exercise/Conversion
Option to purchase Common Stock
2022-05-13−6,114→ 116,849 totalExercise: $2.69Exp: 2029-09-30→ Common Stock (6,114 underlying)
Footnotes (3)
- [F1]Due to a rounding error, the exercise price for this stock option was inadvertently originally reported as $2.68 per share on the reporting person's Form 3 filed on July 22, 2021.
- [F2]1/4th of the shares subject to this option vested on June 30, 2018 and an additional 1/48th of the aggregate number of shares subject to the option vested on the corresponding day of each month thereafter (or the last day of the month, if there was no corresponding day of the month), subject to the reporting person's continued services to the Issuer through the applicable vesting dates.
- [F3]1/4th of the shares subject to this option vested on October 1, 2020 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter, subject to the reporting person's continued services to the Issuer through the applicable vesting dates.